Results 171 to 180 of about 30,536 (239)

Pediatric T-Lymphoblastic Leukemia With Aberrant B-Cell Marker Expression: A Potential Role for Targeted Therapy. [PDF]

EJHaem
Khanlari M, Wang W, Mead PE, Key L, Liu P, Thakral B, Blackburn PR, Klco JM, Ribeiro R, Sarvode S.   +9 more
europepmc   +1 more source

Epi-Immunotherapy in Cancer Treatment: Mechanisms, Clinical Progress, and Future Directions. [PDF]

Cancer Innov
Lu N, Rong G, Han W.
europepmc   +1 more source

Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation-an evidence-based meta-analysis. [PDF]

Ther Adv Hematol
Hua W, Chen Y, Qi J, Song X, Zhou M, Han Y.   +5 more
europepmc   +1 more source

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study. [PDF]

Blood Cancer J
Aguirre LE, Stone RM, DeAngelo DJ, Stahl M.   +3 more
europepmc   +1 more source

Low-dose Decitabine Vs best supportive care in older patients with AML and low blast counts: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC leukemia cooperative group and german MDS study group [PDF]

, 2013
AUL, Carlo, BARON, Frédéric, BECKER, Heiko, DE WITTE, Theo, GANSER, Arnold, GERMING, Ulrich, GIAGOUNIDIS, Aristoteles, HAGEMEIJER, Anne, LABAR, Boris, LUBBERT, Michael, MUUS, Petra, PFLUGER, Karl-Heinz, PLATZBECKER, Uwe, RUTER, Björn, SALIH, Helmut R., SCHAEFER, Hans-Eckart, SELLESLAG, Dominik, SUCIU, Stefan, WIJERMANS, Pierre W.   +18 more
core  

Venetoclax-Based Therapy for Early Relapse in Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Minireview. [PDF]

Cancer Rep (Hoboken)
Du Y, Hassani MA, Li C, Zhao Z, Liu Y, Zhang C, Yan J.   +6 more
europepmc   +1 more source

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies. [PDF]

Br J Haematol
Savona MR, Odenike O, Roboz GJ, Amin H, DeZern AE, Griffiths EA, Dao KH, Zeidan AM, Bhatnagar B, Buckstein R, Leber B, Keating MM, Ball S, Oganesian A, Sano Y, Keer HN, Garcia-Manero G.   +16 more
europepmc   +1 more source

Novel approaches to the use of hypomethylating agents in myeloid malignancies. [PDF]

Epigenomics
Cheng J, O'Connell C, O'Connell C.
europepmc   +1 more source

PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinoma. [PDF]

Int J Biol Sci
Wang P, Xiao R, Chen J, Guan P, Heng HL, Liu L, Wang Y, Zeng X, Zhong G, Hao J, Gao J, Chan JY, Dima S, Ong CK, Teh BT, Li M, Hong JH, Tan J.   +17 more
europepmc   +1 more source

Decitabine suppresses tumor growth by activating mouse mammary tumor virus and interferon-β pathways. [PDF]

Biomol Biomed
Johnson R, Brola A, Wycoff C, Wycoff W, Neumeyer S, Tuttle R, Light S, Li J, Christensen S, Liu Y.   +9 more
europepmc   +1 more source